Aker BioMarine Balance Sheet Health

Financial Health criteria checks 5/6

Aker BioMarine has a total shareholder equity of $355.5M and total debt of $182.2M, which brings its debt-to-equity ratio to 51.3%. Its total assets and total liabilities are $810.1M and $454.6M respectively. Aker BioMarine's EBIT is $2.1M making its interest coverage ratio 0.1. It has cash and short-term investments of $16.3M.

Key information

51.3%

Debt to equity ratio

US$182.20m

Debt

Interest coverage ratio0.08x
CashUS$16.30m
EquityUS$355.50m
Total liabilitiesUS$454.60m
Total assetsUS$810.10m

Recent financial health updates

Recent updates

At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Aug 20
At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?

Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

Jul 19
Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking

What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

Jul 16
What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Jul 11
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

Jun 03
These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way

There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

Feb 15
There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues

There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Nov 06
There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital

Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

Sep 06
Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)

We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Nov 04
We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings

Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Apr 13
Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability

Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Feb 18
Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Jan 07
Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven

Financial Position Analysis

Short Term Liabilities: AKBM's short term assets ($562.5M) exceed its short term liabilities ($41.1M).

Long Term Liabilities: AKBM's short term assets ($562.5M) exceed its long term liabilities ($413.5M).


Debt to Equity History and Analysis

Debt Level: AKBM's net debt to equity ratio (46.7%) is considered high.

Reducing Debt: AKBM's debt to equity ratio has reduced from 187% to 51.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable AKBM has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: AKBM is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 30.2% per year.


Discover healthy companies